Europe Metagenomics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
to 2027 - Regional Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Country

No. of Pages: 138    |    Report Code: TIPRE00003321    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Metagenomics Market

PART 1. iNTRODUCTION

1.1    Scope of the Study

1.2    The Insight Partners Research Report Guidance

PART 2. Europe Metagenomics Market – Key takeaways

PART 3. Europe Metagenomics market –  market landscape

3.1    overview

3.2    market segmentation

3.2.1    Europe Metagenomics Market – By Product

3.2.2    Europe Metagenomics Market – By Application

3.2.3    Europe Metagenomics Market – By Country

3.3    PEST Analysis

PART 4. Europe Metagenomics market- Key Market Dynamics

4.1    Key Market Drivers

4.1.1    Technological Advancements in Metagenomics

4.1.2    Growing Preference for Metagenomics Over Traditional Methods

4.1.3    Wide Range of  Metagenomics Applications

4.2    Key Market Restraints

4.2.1    Highly Priced Metagenomics Technology

4.3    Key Market Opportunities

4.3.1    Precision Metagenomic Analysis- Ushering In The Era Of Precision Medicine

4.4    Key Market Trends

4.4.1    Increasing Inclination towards Molecular-Based Approaches

4.5    Impact analysis

PART 5. Metagenomics market – Europe Analysis

5.1    Europe Metagenomics market Revenue Forecasts and Analysis

5.2    Market positioning

5.3    PERFORMANCE OF KEY PLAYERS

Illumina, Inc.

Qiagen

5.4    expert opinions

PART 6. Europe Metagenomics market Analysis –  By Product

6.1    Overview

6.2    EUROPE metagenomics MARKET, BY product, 2018 & 2027 (%)

6.3    Europe Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

6.4    Instruments & Software Market

6.4.1    Overview

6.4.2    Europe Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)

6.5    Consumables Market

6.5.1    Overview

6.5.2    Europe Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

PART 7. Europe Metagenomics market Analysis –  By Application

7.1    Overview

7.2    EUROPE Metagenomics MARKET, BY application, 2018 & 2027 (%)

7.3    Europe Metagenomics market Revenue And Forecasts to 2027, By Application (US$ Mn)

7.4    Clinical Diagnostic Market

7.4.1    Overview

7.4.2    Europe Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)

7.5    Drug Discovery metagenomics Market

7.5.1    Overview

7.5.2    Europe Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

7.6    Others Market

7.6.1    Overview

7.6.2    Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

PART 8. Europe Metagenomics market Revenue and Forecasts  to 2027

8.1    Overview

8.2    Europe Metagenomics Market Revenue And Forecasts to 2027, By Country (%)

8.3    UK Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.3.1    UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.2    UK Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.3.3    UK Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

8.4    Germany Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.4.1    Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.2    Germany Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.4.3    Germany Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

8.5    France Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.5.1    France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.2    France Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.5.3    France Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

PART 9. Metagenomics Market –Industry Landscape

9.1    Overview

9.2    Growth Strategies in the Metagenomics Market, 2015-2018

9.3    Organic Developments

9.3.1    Overview

9.4    Organic Growth Strategies in the METAGENOMICS Market, 2015-2018

9.5    Product Launch

9.5.1    Recent Product Launch By Players In The Metagenomics Market

9.6    Product approval

9.6.1    Recent Product Approval By Players In The Metagenomics Market

9.7    Expansion & Others

9.7.1    The Metagenomics Market By Expansion & Other Growth Strategies

9.8    Inorganic developments

9.8.1    Overview

9.9    inOrganic Growth Strategies in the Metagenomics Market, 2015-2018

9.10   Acquisitions

9.10.1 Acquisitions By Players In The Metagenomics Market

9.11   Agreements

9.11.1 The Metagenomics Market By Agreements

9.12   Partnership & Collaboration

9.12.1 Partnership By Players In The Metagenomics Market

PART 10. Metagenomics Market–Key company profiles

10.1   Merck KGaA

10.1.1  Key Facts

10.1.2  Business Description

10.1.3  Financial Overview

10.1.4  Product Portfolio

10.1.5  SWOT Analysis

10.1.6  Key Developments

10.2   Thermo Fisher Scientific, Inc.

10.2.1  Key Facts

10.2.2  Business Description

10.2.3  Financial Information

10.2.4  Product Portfolio

10.2.5  SWOT Analysis

10.2.6  Key Developments

10.3   Agilent Technologies, Inc.

10.3.1  Key Facts

10.3.2  Business Description

10.3.3  Financial Overview

10.3.4  Product Portfolio

10.3.5  SWOT Analysis

10.3.6  Key Developments

10.4   QIAGEN

10.4.1  Key Facts

10.4.2  Business Description

10.4.3  Financial Overview

10.4.4  Product Portfolio

10.4.5  SWOT Analysis

10.4.6  Key Developments

10.5   Bio-Rad Laboratories, Inc.

10.5.1  Key Facts

10.5.2  Business Description

10.5.3  Financial Information

10.5.4  Product Portfolio

10.5.5  SWOT Analysis

10.5.6  Key Developments

10.6   Perkin Elmer, inc.

10.6.1  Key Facts

10.6.2  Business Description

10.6.3  Financial Overview

10.6.4  Product Portfolio

10.6.5  SWOT Analysis

10.6.6  Key Developments

10.7   Illumina, Inc.

10.7.1  Key Facts

10.7.2  Business Description

10.7.3  Financial Overview

10.7.4  Product Portfolio

10.7.5  SWOT Analysis

10.7.6  Key Developments

10.8   F. Hoffmann-La Roche Ltd.

10.8.1  Key Facts

10.8.2  Business Description

10.8.3  Financial Overview

10.8.4  Product Portfolio

10.8.5  SWOT Analysis

10.8.6  Key Developments

10.9   Oxford Nanopore Technologies Ltd.

10.9.1  Key Facts

10.9.2  Business Description

10.9.3  Financial Overview

10.9.4  Product & Services Portfolio

10.9.5  SWOT Analysis

10.9.6  Key Developments

10.10 Pacific Bioscience of California, inc.

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Financial Overview

10.10.4 Product & Services Portfolio

10.10.5 SWOT Analysis

10.10.6 Key Developments

PART 11.  Appendix

11.1   About The Insight Partners

11.2   Glossary of Terms

11.3   Methodology

11.3.1  Coverage

11.3.2  Secondary Research

11.3.3  Primary Research

 

LIST OF TABLES

TABLE 1.       Europe Metagenomics market Revenue And Forecasts to 2025, By product (US$ Mn)

TABLE 2.       Europe Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 3.       UK Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 4.       UK Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 5.       Germany Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 6.       Germany Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 7.       France Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 8.       France Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 9.       Recent Product Launch in the Metagenomics Market

TABLE 10.      Recent Product Approval and Enhancements in the Metagenomics Market

TABLE 11.      the Metagenomics Market by Exansion & Others Strategies

TABLE 12.      Acquisitions in the Metagenomics Market

TABLE 13.      the Metagenomics Market by Agreements

TABLE 14.      partnership in the Metagenomics Market

TABLE 15.      Glossary of Terms, Metagenomics market

 

LIST OF FIGURES

FIGURE 1.      GErmany Metagenomics market, Revenue (US$ Mn), By 2018 & 2027

FIGURE 2.      Europe Metagenomics Market By product, Market Share (%), 2018

FIGURE 3.      Europe Metagenomics Market By application, Market Share (%), 2018

FIGURE 4.      Metagenomics market Segmentation

FIGURE 5.      Europe PEST Analysis

FIGURE 6.      Metagenomics market impact analysis of drivers & Restraints

FIGURE 7.      Europe Metagenomics market – Revenue Forecasts and Analysis – 2017- 2027

FIGURE 8.      Europe metagenomics market By Product, 2018 & 2027 (%)

FIGURE 9.      Europe Instruments & software Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 10.    Europe Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 11.    Europe Metagenomics market By application, 2018 & 2027 (%)

FIGURE 12.    Europe Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 13.    Europe Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 14.    Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 15.    Europe Metagenomics Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 16.    Europe metagenomics Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 17.    UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.    Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.    France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 20.    Growth Strategies in the Metagenomics Market, 2015-2018

FIGURE 21.    Organic Growth Strategies in the METAGENOMICS Market, 2015-2018

FIGURE 22.    Inorganic developments in the Metagenomics Market, 2015-2018

The List of Companies - Europe Metagenomics Market

The List of Companies - Europe Metagenomics Market

  1. Merck KGaA
  2. Thermo Fisher Scientific Inc.
  3. Agilent Technologies
  4. Qiagen
  5. Bio-Rad Laboratories, Inc.
  6. Perkinelmer Inc.
  7. Illumina Inc.
  8. F Hoffman-La Roche Ltd.
  9. Oxford Nanopore Technologies Ltd.
  10. Pacific Bioscience of California, Inc.